AJCC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


American Journal of Critical Care. 2003;12: 343-348
Copyright © 2003 by the American Association of Critical-Care Nurses.
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Respond to This Article
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Wit, M.
Right arrow Articles by Epstein, S. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Wit, M.
Right arrow Articles by Epstein, S. K.

Administration of Sedatives and Level of Sedation: Comparative Evaluation via the Sedation-Agitation Scale and the Bispectral Index

By Marjolein de Wit, MD and Scott K. Epstein, MD. From the Pulmonary and Critical Care Division, New England Medical Center and Tufts University School of Medicine, Boston, Mass.


    Abstract
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 
Objectives To compare levels of sedation in patients receiving continuous intravenous infusions of sedative/hypnotic or narcotic agents with levels in patients not receiving infusions and to compare subjective (Sedation-Agitation Scale) and objective (Bispectral Index) evaluations of sedation.

Methods Patients receiving mechanical ventilation in a medical intensive care unit were evaluated prospectively. Level of sedation was assessed with the Sedation-Agitation Scale (range 1–7, unarousable to dangerous agitation) and the Bispectral Index (range 0–100, flat line to awake waveform) recorded before and after stimulation. Patients were classified as receiving continuous infusions if an infusion had been administered within 24 hours preceding assessment.

Results Nineteen patients were evaluated on 80 occasions. Scores on the Sedation-Agitation Scale ranged from 1 to 5 (mean 2.6 and median 2) and correlated highly with values for the Bispectral Index (R2 = 0.48 before and 0.44 after stimulation, P < .001). Patients receiving continuous infusions were more deeply sedated than were patients receiving boluses or no medication (mean [SD] scores, Sedation-Agitation Scale: 2.1 [1.2] vs 3.3 [1.0], P < .001; Bispectral Index before stimulation: 63 [24] vs 86 [13], P < .001). Patients receiving continuous infusions were more likely to have a score of 2 or less on the Sedation-Agitation Scale (32/44 vs 8/35, P < .001).

Conclusion Objective and subjective assessments of sedation are highly correlated. Use of continuous infusions is associated with deeper levels of sedation, and patients receiving continuous infusions are more likely to be oversedated. Sedation therapy should be guided by subjective or objective assessment.


Use of continuous infusion of sedatives/hypnotics in patients receiving mechanical ventilation in intensive care units (ICUs) has been associated with prolonged mechanical ventilation.1,2 The durations of continuous infusions and of mechanical ventilation can be decreased by using a sedation algorithm or by using a strategy of daily interruption of continuously infused sedatives.2,3

When sedatives are delivered as bolus doses, on an as-needed basis, drugs are principally given when patients are agitated. This strategy may prevent accumulation of sedatives by allowing the drugs to be eliminated between doses. In contrast, once a continuous infusion of sedative is started, a reduction in the dose of medications infused may be less likely unless mandated by one of the strategies just mentioned. Under these circumstances, the drug may be more likely to accumulate, and oversedation may occur.


Use of continuous infusions of sedatives/hypnotics prolongs duration of mechanical ventilation.

 

To assess the level of sedation, investigators have used a number of subjective clinical scoring systems and objective assessment with the Bispectral Index (BIS).4–8 Few studies9,10 included correlations between results obtained with subjective and objective assessment techniques, especially in patients receiving mechanical ventilation in medical ICUs.

We hypothesized that continuous infusions of sedatives would be associated with deeper levels of sedation. We therefore compared the level of sedation in patients managed with continuous infusions with the level in patients managed with boluses or no medication. We also compared the use of 2 distinct sedation assessment tools: the Sedation-Agitation Scale (SAS) and the BIS.5


    Methods
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 
All patients 18 years old or older who were receiving mechanical ventilation in the medical ICU were eligible for participation. The study was approved by the institutional human investigation review committee, and verbal consent was obtained from the patients or next of kin.

Exclusion criteria included the following: severe neurological disease (stroke with resultant aphasia, paresis, or paralysis), severe dementia or mental retardation (requiring placement in a skilled nursing facility or assistance with most activities of daily living), anoxic encephalopathy, and paralysis including that due to neuromuscular blockade. All patients were studied while they received full ventilatory support.


Using the Sedation-Agitation Scale and the Bispectral Index, investigators compared daily sedation assessments of patients receiving mechanical ventilation and continuous infusions of sedatives/hypnotics with patients who were not receiving continuous infusions.

 

Assessment of Sedation
Sedation was assessed by using both the SAS (Table 1Go) and the BIS (BIS A-2000, Aspect Medical Systems, Newton, Mass).5 The BIS is a calculation of depth of sedation. Completely awake patients have scores from 90 to 100 on the BIS; consciously sedated patients, 70 to 89; patients under general anesthesia, 50 to 69; and deeply sedated and comatose patients, 0 to 50.10


View this table:
[in this window]
[in a new window]
 
Table 1 Sedation-Agitation Scale

 
Study Design
Patients were studied once per day up to the time of extubation or until tracheostomy. Each patient was evaluated by a clinician thoroughly trained in use of the SAS during a 2-month lead-in period. The clinician scored the SAS, and the principal investigator (M.dW.) assessed the BIS. Once the signal quality was optimized, patients were allowed to rest for a least 15 minutes before evaluation. Immediately before the clinician entered the patient’s room, the principal investigator obtained a baseline BIS value by averaging BIS values measured every 15 seconds for 2 minutes (mean BIS value before stimulation). Next, the clinician entered the room and assessed the patient by using the SAS. At this point, the BIS values were again obtained by averaging values measured every 15 seconds for 2 minutes (mean BIS value after stimulation). Each investigator was blinded to the measurements made by the other. Only the principal investigator could see the BIS screen.

Definitions
A patient was classified as having received continuous intravenous sedation if an infusion of a sedative/hypnotic or narcotic, with or without additional sedative boluses, had been administered at any point during the 24 hours preceding evaluation. All other patients were classified as receiving bolus or no sedation. Oversedation was defined as a score of 2 or less on the SAS, and undersedation (or agitation) was defined as a score of 5 or greater on the SAS. Sedation was considered optimal when the SAS score was 3 or 4. No protocol based on a sedation score was used during the study.

Analysis
The relationships between scores on the SAS and BIS values and between mean scores on the BIS before and after stimulation were analyzed by using Pearson correlation. To compare patients studied while receiving continuous intravenous sedation with patients studied while receiving boluses or no sedation, we used the t test (continuous variables, data normally distributed), the Wilcoxon test (continuous variables, data not normally distributed), or the {chi}2 test with the Fisher 2-tailed exact test (dichotomous variables). The statistical software used for the analysis was SPSS, version 6.1 (SPSS Inc, Chicago, Ill).


    Results
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 
The clinical characteristics of the 19 patients (13 men, 6 women) studied are listed in Table 2Go. Reasons for mechanical ventilation were acute lung injury (8 patients), chronic obstructive pulmonary disease (4), cardiac disease (2), acute central nervous system events (2), sepsis (1), gastrointestinal bleeding (1), and pulmonary hypertension (1).


View this table:
[in this window]
[in a new window]
 
Table 2 Characteristics of patients included in the study

 
On 45 occasions, patients were managed with continuous infusions of sedatives/hypnotics (or narcotics), including propofol (34 occasions), lorazepam (18), and narcotics (14); many patients received more than 1 agent. On the remaining 35 occasions, patients received either bolus medication (17 occasions: benzodiazepines 14, narcotics 8) or no sedative/hypnotics or narcotics (18).

Patients were studied on a total of 80 separate occasions. On 1 occasion, the SAS score was inadvertently not recorded. Sixty-eight BIS measurements were made; on 3 of these occasions, mean BIS scores after stimulation could not be determined because of poor signal quality.

The SAS scores ranged from 1 to 5; no patient had a score of 6 or 7 (Figure 1Go). The mean SAS score was 2.6 (SD 1.3) with a median of 2. The BIS values were from 29 to 98, with a mean of 73 (SD 23) before stimulation (median 78, quartiles 50 and 96) and a mean of 76 (SD 23) after stimulation (median 86, quartiles 58 and 95). The mean BIS values before and after stimulation were highly correlated (R2 = 0.79, P < .001; Figure 2Go).



View larger version (12K):
[in this window]
[in a new window]
 
Figure 1 Distribution of scores on the Sedation-Agitation Scale.

 


View larger version (11K):
[in this window]
[in a new window]
 
Figure 2 Correlation between mean values on the Bispectral Index before and after stimulation (R2 = 0.79). Lines on a point indicate the frequency with which the values occurred. Diagonal lines represent regression line with 95% CI.

 
On 64 occasions, the SAS score and the mean BIS values before and after stimulation were measured simultaneously. The mean BIS values increased as the SAS score increased; all patients with SAS scores of 3 or higher had mean BIS values higher than 60 (Table 3Go). For SAS scores of 1 or 2, the range of observed BIS values was very wide (range before stimulation 29–98, after stimulation 31–97). Nevertheless, the SAS scores and the BIS values were significantly correlated (before stimulation R2 = 0.48, P < .001, and after stimulation R2 = 0.44, P < .001; Figure 3Go).


View this table:
[in this window]
[in a new window]
 
Table 3 Mean Bispectral Index for each score on the Sedation-Agitation Scale

 


View larger version (10K):
[in this window]
[in a new window]
 
Figure 3 Relationship between mean scores on the Sedation-Agitation scale and mean Bispectral Index scores before stimulation (R2 = 0.48). Lines on a point indicate the frequency with which the values occurred. Diagonal lines represent regression line with 95% CI.

 
Patients managed with boluses or no sedation at the time of study had a mean SAS score of 3.3 (SD 1.0), whereas patients receiving continuous infusions had a mean SAS score of 2.1 (SD 1.2; P < .001). Patients receiving a continuous infusion were more likely to have an SAS score of 2 or less (32/44 vs 8/35, P<.001). The mean BIS before stimulation for patients receiving continuous infusions was 63 (SD 24), whereas the mean BIS value for patients managed with boluses or no sedation was 86 (SD 13; P<.001). Similar differences were noted for BIS values after stimulation (continuous 66 [SD 23] vs bolus or no sedation 91 (SD 7; P<.001).

To ascertain if the goals of sedation might explain the significant differences between the groups, we analyzed the severity of respiratory failure by examining the level of positive end-expiratory pressure (PEEP) and the ratio of PaO2 to fraction of inspired oxygen (FIO2) at the time of study. Patients managed with boluses had slightly lower PEEP levels (mean [SD] 6 [1] vs 7 [2], P < .001) and higher PaO2/FIO2 ratios than did patients receiving continuous infusions (202 [93] vs 255 [72], P = .01). Nevertheless, when we compared sedation level (assessed by using either SAS or BIS) with PEEP and PaO2/FIO2, only relatively weak correlations were found for mean scores both before and after stimulation: SAS score with PEEP, R2=0.05; SAS score with PaO2/FIO2, R 2=0.11; BIS value with PEEP, R2 = 0.02. Between the PaO2/FIO2 and the BIS value, correlations (R2) were 0.17 (mean before stimulation) and 0.15 (mean after stimulation).


    Discussion
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 
In this study, we addressed 2 questions: What effect does the mode of sedative/hypnotic or narcotic administration have on sedation level? What is the relationship between subjective and objective sedation scales?

We found that patients receiving continuous infusions were more deeply sedated than were patients managed with boluses or no sedation, as indicated by both lower SAS scores and lower BIS values. Patients managed exclusively with boluses or no sedation at the time of the study were more likely to be sedated to the target level used in our ICU, an SAS score of 3 or 4. In contrast, nearly 75% of the time, patients who had received a continuous infusion for sedation had an SAS score of 2 or less.

One explanation for the variability in sedation level may be that the goals of sedation differed between patients managed with boluses and patients treated with continuous infusions. That is, in some patients, a higher level of sedation may have been desirable, and this level could be achieved only with continuous intravenous sedation. To address this possibility, we examined the relationship between mode of sedation and the degree of respiratory failure as reflected by PaO2/FIO2 and the level of PEEP required to achieve this degree of oxygenation. Patients receiving continuous infusions required higher levels of PEEP and had a lower PaO2/FIO2, but the differences (compared with boluses or no sedation) were small, and the correlations between these variables and SAS scores and BIS values were weak. Therefore, we do not think that different sedation goals completely explain the greater level of sedation observed in patients receiving continuous intravenous infusions of sedatives.

When we compared the SAS scores and the BIS values, we found a strong correlation (R2 = 0.48 and 0.44 for BIS values before and after stimulation) in a cohort of patients receiving mechanical ventilation in the medical ICU, stronger than that reported by other investigators. Simmons et al9 compared the BIS values with SAS scores in 63 ICU patients receiving mechanical ventilation and found a stronger correlation for trauma patients (R2 = 0.52) than for medical patients (R2 = 0.10). Riker et al10 noted a good correlation between SAS scores and BIS values (R2=0.37) in 39 patients who had cardiac surgery.


Patients managed with bolus or no sedation had significantly higher scores on the Sedation-Agitation Scale (more agitated) and higher scores on the Bispectral Index (more alert) than did patients receiving continuous infusions of sedatives/hypnotics.

 

For low SAS scores, the range of BIS values was wide. Therefore, some patients deemed to be quite sedated as indicated by a clinical score might actually have had higher levels of awareness. Alternatively, some patients with low SAS scores and high BIS values were sedated but had alpha intrusions (high-frequency electrical activity) due to pain; with the BIS, it may not be possible to distinguish such intrusions from the awake state.11

In summary, use of continuous intravenous infusions of sedative/hypnotic or narcotic agents is associated with deeper levels of sedation, and these patients are more likely to be oversedated (SAS score 2). Continuous infusions may lead to deeper levels of sedation because of higher drug levels and/or changes in context-sensitive half-life, although the mechanism is unknown because the pharmacokinetic data on sedatives/hypnotics in medical ICU patients are limited. In addition, objective and subjective assessments of sedation, as measured by the SAS and BIS, are highly correlated. These data reinforce the need to guide sedation therapy by using some method of assessing sedation; our results suggest that either subjective or objective techniques can be used.


Patients receiving continuous infusions of sedatives were more deeply sedated than were patients receiving sedatives by bolus.

Although the need for greater levels of sedation was desired in some patients because of the degree of respiratory failure, differing sedation goals did not completely explain all of the differences found.

 


    ACKNOWLEDGMENTS
 
Financial support for this study was provided by a grant from the National Institutes of Health (NIH 5T32 HL07053) and Aspect Medical Systems, Newton, Mass.

To purchase reprints, contact The InnoVision Group, 101 Columbia, Aliso Viejo, CA 92656. Phone, (800) 809-2273 or (949) 362-2050 (ext 532); fax, (949) 362-2049; e-mail, reprints{at}aacn.org.

Commentary by Mary Jo Grap (see shaded boxes).


    REFERENCES
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 

  1. Kollef MH, Levy NT, Ahrens TS, Schaiff R, Prentice D, Sherman G. The use of continuous IV sedation is associated with prolongation of mechanical ventilation. Chest. 1998;114:541–548.[Abstract/Free Full Text]
  2. Brook AD, Ahrens TS, Schaiff R, et al. Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med. 1999;27:2609–2615.[Medline]
  3. Kress JP, Pohlman AS, O’Connor MF, Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med. 2000;342:1471–1477.[Abstract/Free Full Text]
  4. Ramsay MA, Savege TM, Simpson BR, Goodwin R. Controlled sedation with alphaxalone-alphadolone. Br Med J. 1974;2:656–659.[Abstract/Free Full Text]
  5. Riker RR, Picard JT, Fraser GL. Prospective evaluation of the Sedation-Agitation Scale for adult critically ill patients. Crit Care Med. 1999;27:1325–1329.[Medline]
  6. Ambuel B, Hamlett KW, Marx CM, Blumer JL. Assessing distress in pediatric intensive care environments: the COMFORT scale. J Pediatr Psychol. 1992;17:95–109.[Abstract/Free Full Text]
  7. Sessler CN, Gosnell MS, Grap MJ, et al. A new agitation-sedation scale for critically ill patients: development and testing of validity and inter-rater reliability [abstract]. Am J Respir Crit Care Med. 2000;161:A506.
  8. Rampil IJ. A primer for EEG signal processing in anesthesia. Anesthesiology. 1998;89:980–1002.[Medline]
  9. Simmons LE, Riker RR, Prato BS, Fraser GL. Assessing sedation during intensive care unit mechanical ventilation with the Bispectral Index and the Sedation-Agitation Scale. Crit Care Med. 1999;27:1499–1504.[Medline]
  10. Riker RR, Fraser GL, Simmons LE, Wilkins ML. Validating the Sedation-Agitation Scale with the Bispectral Index and Visual Analog Scale in adult ICU patients after cardiac surgery. Intensive Care Med. 2001;27:853–858.[Medline]
  11. Pascualy R, Buchwald D. Chronic fatigue syndrome and fibromyalgia. In: Kryger M, Roth T, Dement W, eds. Principles and Practice of Sleep Medicine. Philadelphia, Pa: WB Saunders Co; 2000:1040–1049.



This article has been cited by other articles:


Home page
The Annals of PharmacotherapyHome page
J. M LeBlanc, J. F Dasta, and S. L Kane-Gill
Role of the Bispectral Index in Sedation Monitoring in the ICU
Ann. Pharmacother., March 1, 2006; 40(3): 490 - 500.
[Abstract] [Full Text] [PDF]


Home page
Am J Crit CareHome page
K. J. Lafleur
Will Adequate Sedation Assessment Include the Use of Actigraphy in the Future?
Am. J. Crit. Care., January 1, 2005; 14(1): 61 - 63.
[Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
B. D Watson and S. L Kane-Gill
Sedation Assessment in Critically Ill Adults: 2001-2004 Update
Ann. Pharmacother., November 1, 2004; 38(11): 1898 - 1906.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Respond to This Article
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Wit, M.
Right arrow Articles by Epstein, S. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Wit, M.
Right arrow Articles by Epstein, S. K.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS